Sponsor or institution
Clinical trials and research at MedPacto, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by MedPacto, Inc. that are recruiting, at sites in 2 countries (most in South Korea (2), United States (1)). 1 was first registered in the last 30 days. By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
Treatment patterns and survival in high-grade osteosarcoma: multicenter retro study
This study tests how patients with high-grade osteosarcoma have fared after first-line treatment across four Korean centers.
-
Assessing the safety and effectiveness of vactosertib for osteosarcoma
This study is testing a new drug called vactosertib to see if it is safe and effective for treating osteosarcoma in teenagers and adults whose cancer has come back or is hard to treat.
Quick answers
How many clinical trials run by MedPacto, Inc. are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.